论文部分内容阅读
1 资料与方法 1.1 病例选择 将1998年3月～2000年3月住院的重度黄疸(血清总胆红素≥171.1μmol/L)病毒性肝炎患者60例,采用1995年第5次全国传染病寄生虫病学术会议修订的病毒性肝炎分型与诊断标准,随机分为治疗组和对照组。治疗组33例,男31例,女2例,其中急性肝炎3例,慢性肝炎重度19例,慢性重型肝炎11例;病原类型为乙型肝炎24例,戊型肝炎3例,乙丁塑、乙丁戊型重叠感染各2例,乙丙型、乙戊型重叠感染各1例。对照组27例,男25例,女2例,其中急性肝炎4例,慢性肝炎重度14例,慢性重型肝炎9例;病原类型为乙型肝炎18例,戊型肝炎3例,甲型肝炎1例,乙甲型重叠感染3例,乙丁型、乙戊型重叠感染各1例。 1.2 治疗方法 对照组采用常规保肝疗法,即每日静滴肝安、
1 Materials and Methods 1.1 Case Selection March 1998 ~ March 2000 hospitalized patients with severe jaundice (serum total bilirubin ≥ 171.1μmol / L) in patients with viral hepatitis 60 cases, the use of 1995 fifth national infectious disease parasitism Worm disease conference revised viral hepatitis classification and diagnostic criteria, were randomly divided into treatment group and control group. The treatment group, 33 cases, 31 males and 2 females, including 3 cases of acute hepatitis, 19 cases of severe chronic hepatitis, chronic severe hepatitis in 11 cases; pathogen types of hepatitis B in 24 cases, hepatitis E in 3 cases, 2 cases of etoposide overlap infection in each case, B, C and E overlap infection in 1 case. The control group of 27 cases, 25 males and 2 females, including 4 cases of acute hepatitis, severe chronic hepatitis in 14 cases, 9 cases of chronic severe hepatitis; pathogenic type of hepatitis B in 18 cases, hepatitis E in 3 cases, hepatitis A For example, there were 3 cases of overlapped type A and 1 case of overlapped type B and B respectively. 1.2 treatment control group using conventional hepatoprotective therapy, that is daily intravenous drip Gan,